SENSEX NIFTY
May 15, 2012, 03.50 PM IST | Source: Moneycontrol.com

AstraZeneca Mar '12 sales at Rs 91.79 crore

AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12

AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12.
For the quarter ended Mar 2011 the sales turnover was Rs 126.68 crore and net profit was Rs 8.35 crore.
Quarterly Results of AstraZeneca Pharma-------- in Rs. Cr. --------
Mar '11Dec '11Mar '12
Sales Turnover126.68153.4891.79
Other Income2.201.502.01
Total Income128.88154.9993.80
Total Expenses110.08131.10140.95
Operating Profit16.6022.38-49.16
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit18.8023.88-47.15
Interest------
PBDT18.8023.89-47.14
Depreciation1.761.891.81
Depreciation On Revaluation Of Assets------
PBT17.0422.00-48.95
Tax8.697.06-15.95
Net Profit8.3514.94-33.00
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share3.345.97--
Book Value------
Equity5.005.005.00
Reserves------
Face Value2.002.002.00
Source : Dion Global Solutions Limited
Set email alert for

ADS BY GOOGLE

video of the day

See earnings growth spike, big reforms in 2015: Envision

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.